GR3018651T3 - Treatment of ocular hypertention with a synergistic combination - Google Patents

Treatment of ocular hypertention with a synergistic combination

Info

Publication number
GR3018651T3
GR3018651T3 GR960400014T GR960400014T GR3018651T3 GR 3018651 T3 GR3018651 T3 GR 3018651T3 GR 960400014 T GR960400014 T GR 960400014T GR 960400014 T GR960400014 T GR 960400014T GR 3018651 T3 GR3018651 T3 GR 3018651T3
Authority
GR
Greece
Prior art keywords
treatment
synergistic combination
ocular
hypertention
oculo
Prior art date
Application number
GR960400014T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of GR3018651T3 publication Critical patent/GR3018651T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
GR960400014T 1990-05-22 1996-01-11 Treatment of ocular hypertention with a synergistic combination GR3018651T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13291090 1990-05-22

Publications (1)

Publication Number Publication Date
GR3018651T3 true GR3018651T3 (en) 1996-04-30

Family

ID=15092386

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400014T GR3018651T3 (en) 1990-05-22 1996-01-11 Treatment of ocular hypertention with a synergistic combination

Country Status (10)

Country Link
US (1) US5166175A (el)
EP (1) EP0458590B1 (el)
JP (1) JP2511585B2 (el)
KR (1) KR960010435B1 (el)
AT (1) ATE132750T1 (el)
CA (1) CA2042937C (el)
DE (1) DE69116224T2 (el)
DK (1) DK0458590T3 (el)
ES (1) ES2084771T3 (el)
GR (1) GR3018651T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
PT561073E (pt) * 1992-03-19 2002-04-29 R Tech Ueno Ltd Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
EP0668076B1 (en) * 1992-08-26 2002-09-04 Sucampo AG Stabilization of a prostanoic acid compound
JPH06107547A (ja) * 1992-10-01 1994-04-19 Aarutetsuku Ueno:Kk 眼科用組成物
US20020133009A1 (en) * 2001-03-13 2002-09-19 Lambrou George N. Method for opening potassium channels
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
SI3431074T1 (sl) 2010-07-29 2022-07-29 Allergan, Inc. Raztopine bimatoprosta in timolola brez konzervansov
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
US4952581A (en) * 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0366279B1 (en) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Ocular hypotensive agents

Also Published As

Publication number Publication date
DK0458590T3 (da) 1996-02-05
ATE132750T1 (de) 1996-01-15
KR960010435B1 (ko) 1996-08-01
CA2042937C (en) 2002-04-30
EP0458590B1 (en) 1996-01-10
JPH04253911A (ja) 1992-09-09
DE69116224T2 (de) 1996-05-23
EP0458590A1 (en) 1991-11-27
ES2084771T3 (es) 1996-05-16
JP2511585B2 (ja) 1996-06-26
DE69116224D1 (de) 1996-02-22
US5166175A (en) 1992-11-24
KR910019621A (ko) 1991-12-19
CA2042937A1 (en) 1991-11-23

Similar Documents

Publication Publication Date Title
GR3027666T3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
CA2019974A1 (en) Treatment of inflammation
AU6488294A (en) Hypoglycemic agents
BG106065A (en) Method for the treatment of neurological or neuropsychiatric disorders
GB2223404B (en) Inositoltrisphosphate for the treatment of abnormal levels of lipoproteins
GR3018651T3 (en) Treatment of ocular hypertention with a synergistic combination
GR3019058T3 (en) 3-Arylcarbonyl-1-aminoalkyl-1H-indole containing antiglaucoma compositions
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
AU3689193A (en) Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
EP0430551A3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
ITRM930198A0 (it) Regolazione automatica del contrasto e della luminosita' per apparecchi a diagramma entropico integrati in aeromobili.
ZA913920B (en) Therapeutic compound
EP0469782A3 (en) Treatment of cataract with prostacyclin compounds